However, other mechanisms, such as a direct phosphorylation of tau/APP by Chk1, and involvement of downstream targets of Chk1 other than CIP2A, may also participate in DNA damage–promoted AD pathogenesis, which needs further exploration. This evidence concerns the gene CIP2A and Alzheimer disease.